Additionally, ADAM17 is highly expressed in drug-resistant colorectal cancer cells; however, miR-324-3p and miR-222 can suppress ADAM17 protein expression to restore drug sensitivity [48,49]. This evidence concerns the gene ADAM17 and colorectal cancer.